Improvement in outcomes of clinical islet transplantation: 1999-2010

Diabetes Care

Volumn 35, Issue 7, 2012, Pages 1436-1445

  Barton, Franca B ^a   Rickels, Michael R ^b   Alejandro, Rodolfo ^c   Hering, Bernhard J ^d   Wease, Stephen ^a   Naziruddin, Bashoo ^e   Oberholzer, Jose ^f   Odorico, Jon S ^g   Garfinkel, Marc R ^h   Levy, Marlon ⁱ   Pattou, Francois ^j   Berney, Thierry ^k   Secchi, Antonio ^l   Messinger, Shari ^c   Senior, Peter A ^m   Maffi, Paola ^l   Posselt, Andrew ⁿ   Stock, Peter G ⁿ   Kaufman, Dixon B ^g   Luo, Xunrong ^o   Kandeel, Fouad ^p   Cagliero, Enrico ^q   Turgeon, Nicole A ^r   Witkowski, Piotr ^s   Naji, Ali ^b   O'Connell, Philip J ^t   Greenbaum, Carla ^u   Kudva, Yogish C ^v   Brayman, Kenneth L ^w   Aull, Meredith J ^x   Larsen, Christian ^r   Kay, Tom W H ^y   Fernandez, Luis A ^g   Vantyghem, Marie Christine ^j   Bellin, Melena ^d   Shapiro, A M James ^m   more..

^a EMMES CORPORATION   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^h SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^j UNIV LILLE   (France)

^k GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^l VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^m UNIVERSITY OF ALBERTA   (Canada)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o NORTHWESTERN UNIVERSITY   (United States)

^p Division of Diabetes Endocrinology and Metabolism   (United States)

^q MASSACHUSETTS GENERAL HOSPITAL   (United States)

^r EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY OF CHICAGO   (United States)

^t WESTMEAD HOSPITAL   (Australia)

^u BENAROYA RESEARCH INSTITUTE   (United States)

^v MAYO CLINIC   (United States)

^w UNIVERSITY OF VIRGINIA   (United States)

^x WEILL CORNELL MEDICAL COLLEGE   (United States)

^y ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CELL FUNCTION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PANCREAS ISLET TRANSPLANTATION; POSTOPERATIVE CARE; PROTEIN BLOOD LEVEL; RISK REDUCTION; TREND STUDY;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MIDDLE AGED; REGISTRIES; TREATMENT OUTCOME;

EID: 84862892304     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0063     Document Type: Article

References (24)

1. Hering BJ, Ricordi C. Islet transplantation for patients with type 1 diabetes. Graft 1999;2:12-27
2. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-238 (Pubitemid 30490390)
3. The Collaborative Islet Transplant Registry (CITR). Seventh Annual Data Report [online report], 2011. Available fromhttp:// www.citregistry.org/reports/ reports.htm. Accessed 9 January 2012
4. Ryan EA, Shandro T, Green K, et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004;53:955-962 (Pubitemid 38436607)
5. Clinical Islet Transplantation Consortium (CIT) [online]. Available from http://www2. niddk.nih.gov/Research/ScientificAreas/ Pancreas/EndocrinePancreas/ CITT.htm. Accessed 9 January 2012
6. U.S. Food and Drug Administration. Safety. What is a Serious Adverse Event? [online]. Available from http://www.fda. gov/medWatch/report/DESK/ advevnt. htm. Accessed 9 January 2012
7. Ryan EA, Paty BW, Senior PA, et al. Fiveyear follow-up after clinical islet transplantation. Diabetes 2005;54:2060-2069 (Pubitemid 40911269)
8. Shapiro AMJ, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006;355:1318-1330 (Pubitemid 44465460)
9. Bellin MD, Barton FB, Heitman A, et al. Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am J Transplant 11 April 2012 . [Epub ahead of print]
10. Alejandro R, Barton FB, Hering BJ, Wease S; Collaborative Islet Transplant Registry Investigators. 2008 Update from the Collaborative Islet Transplant Registry. Transplantation 2008;86:1783-1788
11. Senior PA, Zeman M, Paty BW, Ryan EA, Shapiro AM.Changes in renal function after clinical islet transplantation: four-year observational study. Am J Transplant 2007;7: 91-98 (Pubitemid 44952860)
12. Maffi P, Bertuzzi F, De Taddeo F, et al. Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy. Diabetes Care 2007;30: 1150-1155 (Pubitemid 46684640)
13. Rickels MR, Kearns J, Markmann E, et al. HLA sensitization in islet transplantation. Clin Transpl 2006:413-420
14. Campbell PM, Senior PA, Salam A, et al. High risk of sensitization after failed islet transplantation. Am J Transplant 2007;7: 2311-2317 (Pubitemid 47347848)
15. Cardani R, Pileggi A, Ricordi C, et al. Allosensitization of islet allograft recipients. Transplantation 2007;84:1413-1427 (Pubitemid 350294716)
16. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005;293:830-835 (Pubitemid 40250366)
17. Bellin MD, Kandaswamy R, Parkey J, et al. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant 2008;8: 2463-2470
18. Ponte GM, Pileggi A, Messinger S, et al. Toward maximizing the success rates of human islet isolation: influence of donor and isolation factors. Cell Transplant 2007; 16:595-607 (Pubitemid 351448274)
19. Deng S, Vatamaniuk M, Huang X, et al. Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 2004;53:624-632 (Pubitemid 38270631)
20. Johansson H, Lukinius A, Moberg L, et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005;54: 1755-1762 (Pubitemid 40770765)
21. U.S. Department of Health and Human Services. Health Resources and Services Administration, OPTN/SRTR Annual Report: Table 6.11, Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants [online]. Available from http://www. ustransplant.org/annual-reports/current/ 611-pta.htm. Accessed 9 January 2012
22. Gruessner RW, Sutherland DE, Kandaswamy R, Gruessner AC. Over 500 solitary pancreas transplants in nonuremic patients with brittle diabetes mellitus. Transplantation 2008;85:42-47
23. Rickels MR, Mueller R, Teff KL, Naji A. beta-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants. J Clin Endocrinol Metab 2010; 95:1238-1246
24. Rickels MR, Chiou AJ, Fuller C, et al. Beta-cell secretory capacity after human islet transplantation by the CIT07 vs. Edmonton Protocol: preliminary results. Am J Transplant 2011;11(Suppl. 2):79-80